1JS vs HIK: Side-by-Side Comparison
Compare Shield Therapeutics plc (1JS) and Hikma Pharmaceuticals PLC (HIK) side by side: market cap EUR 72.73M vs GBX 3.30B. Financials, growth and model signals on Bullrun.
| Metric | 1JS | HIK |
|---|---|---|
| Company | Shield Therapeutics plc | Hikma Pharmaceuticals PLC |
| Country / Exchange | United Kingdom · F | United Kingdom · LSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 72.73M | GBX 3.30B |
| P/E ratio | — | 11.5 |
| Dividend yield | — | 4.04% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 49.70M | GBP 3.35B |
| Revenue growth YoY | +54.4% | +7.1% |
| Net income | EUR -17.66M | GBP 402.00M |
| Gross margin | 46.4% | 43.0% |
| Diluted EPS | -0.02 | 1.81 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.